200 related articles for article (PubMed ID: 32754032)
1. Cinnamtannin B-1 Prevents Ovariectomy-Induced Osteoporosis
Li M; Hao L; Li L; Liu L; Chen G; Jiang W; Xu W; Zhu C; Yao G; Fang S
Front Pharmacol; 2020; 11():1023. PubMed ID: 32754032
[TBL] [Abstract][Full Text] [Related]
2. Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species.
Chen K; Qiu P; Yuan Y; Zheng L; He J; Wang C; Guo Q; Kenny J; Liu Q; Zhao J; Chen J; Tickner J; Fan S; Lin X; Xu J
Theranostics; 2019; 9(6):1634-1650. PubMed ID: 31037128
[No Abstract] [Full Text] [Related]
3. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities.
Liu Y; Wang C; Wang G; Sun Y; Deng Z; Chen L; Chen K; Tickner J; Kenny J; Song D; Zhang Q; Wang H; Chen Z; Zhou C; He W; Xu J
Theranostics; 2019; 9(16):4648-4662. PubMed ID: 31367247
[No Abstract] [Full Text] [Related]
4. A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-
Wong P; Lv Z; Li J; Wei Q; Xu L; Fang B; Luo Y; He M
Oxid Med Cell Longev; 2022; 2022():5982014. PubMed ID: 36388169
[TBL] [Abstract][Full Text] [Related]
5. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen gas protects against ovariectomy-induced osteoporosis by inhibiting NF-κB activation.
Wu G; Pan L; Sun J; Chen G; Wang S
Menopause; 2019 Jul; 26(7):785-792. PubMed ID: 31083022
[TBL] [Abstract][Full Text] [Related]
7. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
[TBL] [Abstract][Full Text] [Related]
8. Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity.
Lin X; Yuan G; Yang B; Xie C; Zhou Z; Liu Y; Liu Z; Wu Z; Akimoto Y; Li N; Xu R; Song F
Phytomedicine; 2024 Jul; 129():155559. PubMed ID: 38579642
[TBL] [Abstract][Full Text] [Related]
9. TRAF6 Mediates Suppression of Osteoclastogenesis and Prevention of Ovariectomy-Induced Bone Loss by a Novel Prenylflavonoid.
Tan EM; Li L; Indran IR; Chew N; Yong EL
J Bone Miner Res; 2017 Apr; 32(4):846-860. PubMed ID: 27813153
[TBL] [Abstract][Full Text] [Related]
10. Garcinone C attenuates RANKL-induced osteoclast differentiation and oxidative stress by activating Nrf2/HO-1 and inhibiting the NF-kB signaling pathway.
Ji H; Pan Q; Cao R; Li Y; Yang Y; Chen S; Gu Y; Qian D; Guo Y; Wang L; Wang Z; Xiao L
Heliyon; 2024 Feb; 10(3):e25601. PubMed ID: 38333852
[TBL] [Abstract][Full Text] [Related]
11. Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption.
Tian K; Su Y; Ding J; Wang D; Zhan Y; Li Y; Liang J; Lin X; Song F; Wang Z; Xu J; Liu Q; Zhao J
Life Sci; 2020 Mar; 244():117336. PubMed ID: 31972206
[TBL] [Abstract][Full Text] [Related]
12. 6'-O-Galloylpaeoniflorin Attenuates Osteoclasto-genesis and Relieves Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species and MAPKs/c-Fos/NFATc1 Signaling Pathway.
Liu W; Xie G; Yuan G; Xie D; Lian Z; Lin Z; Ye J; Zhou W; Zhou W; Li H; Wang X; Feng H; Liu Y; Yao G
Front Pharmacol; 2021; 12():641277. PubMed ID: 33897430
[TBL] [Abstract][Full Text] [Related]
13. Azilsartan Suppresses Osteoclastogenesis and Ameliorates Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species Production and Activating Nrf2 Signaling.
Pan B; Zheng L; Fang J; Lin Y; Lai H; Gao J; Pan W; Zhang Y; Ni K; Lou C; He D
Front Pharmacol; 2021; 12():774709. PubMed ID: 34899338
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
15. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
16. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
17. Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis.
Kim M; Kim HS; Kim JH; Kim EY; Lee B; Lee SY; Jun JY; Kim MB; Sohn Y; Jung HS
BMC Complement Med Ther; 2020 Feb; 20(1):35. PubMed ID: 32024503
[TBL] [Abstract][Full Text] [Related]
18. Cyperus Rotundus L. extract suppresses RANKL-induced osteoclastogenesis through NFATc1/c-fos downregulation and prevent bone loss in OVX-induced osteoporosis rat.
Kum CJ; Kim EY; Kim JH; Lee B; Min JH; Heo J; Kim JH; Yeom M; Sohn Y; Jung HS
J Ethnopharmacol; 2017 Jun; 205():186-194. PubMed ID: 28315458
[TBL] [Abstract][Full Text] [Related]
19. (-)-Epicatechin 3-O-β-D-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways.
Hsiao HB; Wu JB; Lin WC
BMC Complement Altern Med; 2017 May; 17(1):245. PubMed ID: 28468652
[TBL] [Abstract][Full Text] [Related]
20. VSIG4 inhibits RANKL-induced osteoclastogenesis by enhancing Nrf2-dependent antioxidant response against reactive oxygen species production.
Miao J; Tu Y; Jiang J; Ren R; Wu Q; Liang H; Wang T; Lin B; Wu J; Pan Y; Wang X; Jin H
Int J Biol Macromol; 2024 Mar; 260(Pt 2):129357. PubMed ID: 38216011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]